Ohio’s Minimally Invasive Devices touts $9 million raised in a Series B financing round in support of the FDA-approved FloShield laparoscopic vision systems.
Columbus, Ohio-based medical technology maker Minimally Invasive Devices closed a $9 million Series B financing round in support of its laparoscopic visualization systems.
MID plans to use the funds to forge a direct sales force and expand manufacturing for its FloShield laparoscopic camera attachment, which already has FDA approval for the U.S. market.